Related Experiment Video

Updated: May 12, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Notch2 inhibits proliferation of chronic myeloid leukemia cells

Zesong Yang1, Chunxiu Yang, Shunjun Zhang

  • 1Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing;

Oncology Letters
|April 20, 2013
PubMed

Insights

Overexpressing Notch2 in chronic myeloid leukemia (CML) cells inhibited their proliferation. This Notch signaling activation involved increased NF-κB and TGF-β1, and decreased Bcl-2 expression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Notch signaling pathway plays a role in chronic myeloid leukemia (CML) progression.
  • Understanding Notch pathway modulation is crucial for CML treatment strategies.

Purpose of the Study:

  • To investigate the impact of Notch2 overexpression on K562 CML cell proliferation.
  • To elucidate the underlying molecular mechanisms of Notch2's effect in CML.

Main Methods:

  • Transfection of K562 cells with exogenous intracellular Notch2 (ICN2) using Lipofectamine™ 2000.
  • Analysis of Notch2 mRNA and protein expression levels.
  • Cell cycle analysis (G1 and S phases) and cell counting.
  • Quantitative assessment of Numb, Bcl-2, NF-κB, and TGF-β1 gene expression.

Main Results:

  • Notch2 mRNA and protein expression were significantly upregulated post-ICN2 transfection.
  • K562 cell proliferation was significantly inhibited, with an increase in G1 phase cells and a decrease in S phase cells.
  • NF-κB and TGF-β1 mRNA expression increased, while Bcl-2 mRNA expression decreased; Numb expression remained unchanged.

Conclusions:

  • Exogenous Notch2 overexpression activates the Notch pathway in K562 CML cells.
  • Notch2 overexpression inhibits K562 cell proliferation through modulation of NF-κB, TGF-β1, and Bcl-2 expression.
  • These findings suggest Notch2 as a potential therapeutic target in CML.
Keywords:
Notch signalcell proliferationchronic myeloid leukemiagene transfection

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...